Disruption is the overdue remedy and how this debate can revitalise the PBS

July 10, 2026 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

If there’s one thing to say about the PBS, it’s that public debate around the program has long been stagnant. Narrowly focused on process and technical inputs for too long. It has been the policy equivalent of a stagnant body of water. …

Subscribe now to continue reading.

Latest Video

'But I've said it's really important that these two drugs stay on the PBS'
July 7, 2026 - Latest News
In a perfect world, the minister would not be in this position, and he might question the timeline
July 8, 2026 - Latest News
Aegros completes Australia’s second large scale plasma fractionation plant
July 8, 2026 - Latest News
Illumina taps medtech leader to head Australia and New Zealand operations
July 8, 2026 - Latest News
It might make sense to follow the process, mostly, but no need to keep patients waiting
July 9, 2026 - Latest News

Disruption is the overdue remedy and how this debate can revitalise the PBS

This is a preview of subscriber content

Latest Video

Most Read

'But I've said it's really important that these two drugs stay on the PBS'

In a perfect world, the minister would not be in this position, and he might question the timeline

Aegros completes Australia’s second large scale plasma fractionation plant

Illumina taps medtech leader to head Australia and New Zealand operations

It might make sense to follow the process, mostly, but no need to keep patients waiting

New Stories

Disruption is the overdue remedy and how this debate can revitalise the PBS

Melbourne study links higher tumour radiation dose to longer progression-free survival

Older Australians are underestimating their personal risk from RSV

Territory partnership backs digital health push for diabetes, kidney and heart care

It might make sense to follow the process, mostly, but no need to keep patients waiting

Illumina taps medtech leader to head Australia and New Zealand operations

PYC Therapeutics names Thomas Ulmer as new chief financial officer

Sign In

Disruption is the overdue remedy and how this debate can revitalise the PBS

This is a preview of subscriber content

Latest Video

Most Read

'But I've said it's really important that these two drugs stay on the PBS'

In a perfect world, the minister would not be in this position, and he might question the timeline

Aegros completes Australia’s second large scale plasma fractionation plant

Illumina taps medtech leader to head Australia and New Zealand operations

It might make sense to follow the process, mostly, but no need to keep patients waiting

Follow Us

New Stories

Disruption is the overdue remedy and how this debate can revitalise the PBS

Melbourne study links higher tumour radiation dose to longer progression-free survival

Older Australians are underestimating their personal risk from RSV

Territory partnership backs digital health push for diabetes, kidney and heart care

It might make sense to follow the process, mostly, but no need to keep patients waiting

Illumina taps medtech leader to head Australia and New Zealand operations

PYC Therapeutics names Thomas Ulmer as new chief financial officer